Price T Rowe Associates Inc Eyenovia, Inc. Transaction History
Price T Rowe Associates Inc
- $816 Billion
- Q1 2024
A detailed history of Price T Rowe Associates Inc transactions in Eyenovia, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 10,712 shares of EYEN stock, worth $6,320. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,712Holding current value
$6,320% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding EYEN
# of Institutions
58Shares Held
7.63MCall Options Held
22.1KPut Options Held
9.1K-
Vanguard Group Inc Valley Forge, PA1.79MShares$1.06 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.58MShares$929,4960.0% of portfolio
-
Cowen And Company, LLC828KShares$488,4320.03% of portfolio
-
Geode Capital Management, LLC Boston, MA693KShares$409,0720.0% of portfolio
-
Lasry Marc New York, NY548KShares$323,2060.58% of portfolio
About EYENOVIA, INC.
- Ticker EYEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,212,900
- Market Cap $20.2M
- Description
- Eyenovia, Inc., a clinical stage ophthalmic company, engages in developing therapeutics based on its proprietary microdose array print platform technology. The company focuses on developing clinical microdosing of formulations of ophthalmic pharmaceutical agents using its Optejet branded targeted ocular delivery system. It focuses on the develop...